| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
| Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Methylthioninium chloride 65 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| bisoprololfumarat 2,5 mg + hydrochlorthiazid 6,25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| bisoprololfumarat 2,5 mg + hydrochlorthiazid 6,25 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Mirtazapine 7.5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Azathioprine 75 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Azathioprine 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 30 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Aspirin 325 mg and codeine 60 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and codeine 60 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Nefazodone hydrochloride 300 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| abacavir 600 mg + lamivudin 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| abacavir 600 mg + lamivudin 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amlodipin 2,5 mg + atorvastatin 10 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 2,5 mg + atorvastatin 10 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amlodipin 2,5 mg/atorvastatin 20 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 2,5 mg/atorvastatin 20 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amlodipin 2,5 mg + atorvastatin 40 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 2,5 mg + atorvastatin 40 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
| Hydralazine hydrochloride 100 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydralazine hydrochloride 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Midodrine hydrochloride 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| nelfinavir 625 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nitazoxanide 500 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nizatidine 75 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Amiodarone hydrochloride 400 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| alendronatnatrium 70 mg + cholecalciferol 2800 IE tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| alendronatnatrium 70 mg + cholecalciferol 2800 IE tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| methscopolamin 5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| alosetron 0,5 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Oxandrolone 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Acetylcysteine 600 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aripiprazole 2 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| aliskiren 300 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 10 mg + valsartan 320 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 10 mg + valsartan 320 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| aliskiren 150 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 5 mg + valsartan 160 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 5 mg + valsartan 160 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| alendronatnatrium 70 mg + cholecalciferol 5600 IE tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| alendronatnatrium 70 mg + cholecalciferol 5600 IE tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amlodipin 5 mg + valsartan 320 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 5 mg + valsartan 320 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amlodipin 10 mg + valsartan 160 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 10 mg + valsartan 160 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Astemizole 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Nicotinic acid 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
3 |
| Armodafinil 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Armodafinil 150 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Armodafinil 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ambrisentan 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 10 mg + olmesartan 20 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amlodipin 10 mg + olmesartan 20 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| amitriptylin 12,5 mg + chlordiazepoxid 10 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| amitriptylin 12,5 mg + chlordiazepoxid 10 mg tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Carisoprodol 250 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ambrisentan 5 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely amlodipine besilate 2.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nebivolol 2.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nebivolol 10 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 10 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute specifies the denominator unit for the presentation strength of a product. |
True |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
False |
Tablet (unit of presentation) |
Inferred relationship |
Some |
2 |
FHIR